About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Safety and Tolerability Study of Drug to Treat Schizophrenia

Safety and Tolerability Study of Drug to Treat Schizophrenia

NCT00044005·26 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sumitomo Pharma America, Inc.

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Successful completion of participation in protocol #D1050049

You may not be if

Substance abuse
Prolactin level of ≥200ng/mL at baseline
Pregnancy

The record

StatusCompleted

PhasePhase 2

Taking part98

StartedSep 2002

UpdatedApr 17, 2014

Conditions

Where26

Birmingham Psychiatry Pharmaceutical
Birmingham, Alabama, United States
Institute for Psychopharmacology Research
Cerritos, California, United States
CNS Network
Garden Grove, California, United States